Save time and get answers to complex questions with AI chat
Guselkumab brand name?Drugpatentwatch market analysis industry today?Mobic injection patent oehringer ingelheim france?Alogliptin benz cost?Tenofovir generic patent?
See the DrugPatentWatch profile for keytruda
Keytruda (pembrolizumab) received its first FDA approval in 2014 — specifically on September 4, 2014, for unresectable or metastatic melanoma. If you’d like, I can outline its subsequent FDA-approved indications by year.
Other Questions About Keytruda :